These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1580287)

  • 1. Long-term acceptability of perindopril: European multicenter trial on 856 patients.
    Degaute JP; Leeman M; Desche P
    Am J Med; 1992 Apr; 92(4B):84S-90S. PubMed ID: 1580287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive efficacy and safety of perindopril in mild-to-moderate essential hypertension: results of a double-blind multicenter study versus atenolol.
    Morgan TO; Louis WJ; MacDonald GJ; Conway EL; Bartholomeusz LC; Anderson AI; Cameron DP; Donnelly T; Frewin DB; Hooper MJ
    Am J Med; 1992 Apr; 92(4B):73S-78S. PubMed ID: 1580284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double blind comparison of perindopril and atenolol in essential hypertension.
    Thurston H; Mimran A; Zanchetti A; Creytens G; Rorive G; Brown CL; Santoni JP
    J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive efficacy and acceptability of perindopril in elderly hypertensive patients.
    Suraniti S; Berrut G; Marre M; Fressinaud P
    Am J Cardiol; 1993 Jun; 71(17):28E-31E. PubMed ID: 8328364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and acceptability of perindopril in essential hypertension.
    Sukonthasarn A; Ratanaprakarn R; Koanantakul B; Ngam-Ukos P
    J Med Assoc Thai; 1994 Jun; 77(6):281-7. PubMed ID: 7869013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical acceptability of ACE inhibitor therapy in mild to moderate hypertension, a comparison between perindopril and enalapril.
    Alcocer L; Campos C; Bahena JH; Nacaud A; Parra Carillo J; Calvo C; Weber C; Lerebours G; Mickalonis L; Villahermosa MT
    Cardiovasc Drugs Ther; 1995 Jun; 9(3):431-6. PubMed ID: 8527353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of antihypertensive efficacy of perindopril: results of double-blind multicenter studies versus reference drugs.
    Thurston H; Desche P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S45-9. PubMed ID: 1725202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of perindopril and hydrochlorothiazide-amiloride in mild to moderate essential hypertension.
    Andrejak M; Santoni JP; Carré A; Deruyttere M; Magometschnigg D; Gotzen R; Stumpe KO
    Fundam Clin Pharmacol; 1991; 5(3):185-92. PubMed ID: 1682228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perindopril as monotherapy in hypertension: a multicenter comparison of two dosing regimens. The Perindopril Study Group.
    Chrysant SG; McDonald RH; Wright JT; Barden PL; Weiss RJ
    Clin Pharmacol Ther; 1993 Apr; 53(4):479-84. PubMed ID: 8477565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perindopril versus captopril: efficacy and acceptability in an Italian multicenter trial.
    Agabiti-Rosei E; Ambrosioni E; Finardi G; Folino P; Gambassi G; Malini P; Marchesi E; Muiesan ML; Semplicini A; Pessina AC
    Am J Med; 1992 Apr; 92(4B):79S-83S. PubMed ID: 1580285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perindopril: first-line treatment for hypertension.
    Zanchetti A; Desche P
    Clin Exp Hypertens A; 1989; 11 Suppl 2():555-73. PubMed ID: 2691129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [24-hour effectiveness and tolerance of perindopril (Prestarium), an ACE inhibitor, in the treatment of mild to moderate hypertension. A 1-year Czech and Slovak study].
    Widimský J; Fedelesová V; Uhlír O
    Vnitr Lek; 1995 Jul; 41(7):441-4. PubMed ID: 7571476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects.
    Brown CL; Backhouse CI; Grippat JC; Santoni JP
    Eur J Clin Pharmacol; 1990; 39(4):327-32. PubMed ID: 2076713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibition as first-line treatment for hypertension.
    Thurston H
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():67-71. PubMed ID: 1395119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-line treatment in hypertension. Role of perindopril.
    Zanchetti A
    Drugs; 1990; 39 Suppl 1():71-5. PubMed ID: 2407495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perindopril/hydrochlorothiazide dose combinations for the treatment of hypertension: a multicenter study.
    Chrysant SG
    J Clin Pharmacol; 1997 Jan; 37(1):47-52. PubMed ID: 9048272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
    Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
    Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term (1 year) acceptability of perindopril in type II diabetic patients with hypertension.
    Jandrain B; Herbaut C; Depoorter JC; Voorde KV
    Am J Med; 1992 Apr; 92(4B):91S-94S. PubMed ID: 1580288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new trial of the efficacy, tolerability, and safety of angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies. Perindopril Therapeutic Safety Study Group (PUTS).
    Stumpe KO; Overlack A
    Am J Cardiol; 1993 Jun; 71(17):32E-37E. PubMed ID: 8328365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril versus perindopril: a double blind study in essential hypertension.
    Lees KR; Reid JL; Scott MG; Hosie J; Herpin D; Santoni JP
    J Hum Hypertens; 1989 Feb; 3(1):17-22. PubMed ID: 2657055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.